v3.26.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue:    
Collaboration revenue $ 116,670
Total revenue 116,670
Cost of revenue:    
Cost of collaboration revenue 94,778
Total cost of revenue 94,778
Gross profit 21,892
Operating expenses:    
Research and development 1,799,738 2,223,265
General and administrative 4,816,790 5,013,118
Total operating expenses 6,616,528 7,236,383
Loss from operations (6,594,636) (7,236,383)
Other income (expense), net    
Interest expense (5,629) (18,158)
Interest income 102,197 260,894
Total other income (expense), net 96,568 242,736
Net loss (6,498,068) (6,993,647)
Deemed dividend related to warrant exercise price adjustment (44,985)
Net loss attributable to common stockholders $ (6,498,068) $ (7,038,632)
Net loss per common share attributable to common stockholders - basic $ (0.63) $ (0.85)
Net loss per common share attributable to common stockholders - diluted $ (0.63) $ (0.85)
Weighted average number of shares outstanding - basic 10,337,073 8,245,353
Weighted average number of shares outstanding - diluted 10,337,073 8,245,353

Source

HTML PDF
ZIP